
Service(s) concerned
Structure(s) concerned
November pearl
Lung cancer: expertise and cutting-edge treatments
Therapeutic decisions are made during a weekly thoracic oncology Multidisciplinary Consultation Meeting ( MCM ) bringing together onco-pulmonologists, pulmonologists , a radiotherapist , a radiologist, a nuclear doctor , a thoracic surgeon , an anatomopathologist , a doctor pain specialist and a clinical research associate.
In 2022,
215 lung cancer operations were carried out, including 18 using an innovative robot-assisted minimally invasive surgery technique. This procedure is reserved for patients who suffer from early stage lung cancer. It helps reduce pain, the risk of respiratory complications and hospitalization time. It also promotes better recovery and better healing.
Nearly 3,500 bags of chemotherapy and immunotherapy treatment were also produced by the establishment's Cytotoxic Preparation Unit and dispensed to patients. Each preparation is adapted to the pathology, weight and general condition of the patient.
A wide range of supportive care is also available to patients (social, psychological, nutritional, sophrological and socio-aesthetic care and adapted physical activity ).
The pulmonology department is a reference center for the treatment of thymic tumors and mesothelioma.
Focus on the Pulmonology Continuing Care Unit
In this unit, 6 beds are dedicated to patients followed in the pulmonology and thoracic oncology department presenting complications linked to the disease and/or treatment. Here, they receive close, 24-hour monitoring from the multidisciplinary medical team trained in critical care. Patients hospitalized at USC benefit from modern, automated non-invasive equipment for optimal care. Monitoring systems continuously record the patient's vital parameters and the operation of various devices. Any anomaly is immediately signaled by an alarm.
Innovative therapies thanks to clinical research
The Caen Normandie University Hospital teams are heavily involved in national and/or international clinical trials dedicated to lung cancer. Currently, around twenty clinical trials on lung cancer are being carried out at the University Hospital, particularly at the hospital's Clinical Research Center.
The Clinical Research Center, certified by the DGOS , has site authorization issued by the Normandy Regional Health Agency to carry out phase 1 trials. Patients are cared for by onco-pulmonologists from the Caen University Hospital Normandie, clinical research nurses, study engineers and clinical research associates. Thanks to the clinical trials set up, patients with lung cancer were able to benefit from innovative treatments within the institution (immunotherapy, targeted therapy) at different stages of their development.
Clinical research is an essential step in the development of new innovative drugs and treatments. The aim of clinical trials is to evaluate new treatments and judge their effectiveness and tolerability in patients. Indeed, a drug cannot be made available to patients without prior clinical trials.
Published on November 14, 2023
Share the news
Latest news

Press contacts
Avenue de la Côte de Nacre
CS 30001
14033 CAEN cedex 9